Catequentinib hydrochloride

{
  "id": "MLC-T-ONC-012332",
  "term": "Catequentinib hydrochloride",
  "field": "Oncology and biomedicine",
  "definition": "The hydrochloride salt form of catequentinib, a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, catequentinib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.",
  "abbreviation": "ALTN HCl",
  "synonyms": [
    "1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-quinolyl)oxymethyl)cyclopropanamine, dihydrochloride",
    "anlotinib hydrochloride"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/catequentinib-hydrochloride/"
}